Delivery Order SPE2D021DA002-SPE2D325F103G
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,280.86 on August 18, 2025, for the supply of Isentress 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,093.62 for the supply of Isentress 400 mg tablets (60-count) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a tactical procurement of antiretroviral medication to support Department of Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, for the supply of Isentress 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,093.62. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.99...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order on July 30, 2025, for 60 tablets of Isentress 400 mg with a ceiling value of $6,280.86. This firm fixed-price delivery order, which is due for completion by July 31, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for $2,093.62 on September 29, 2025. The order covers 60 tablets of Isentress 400 mg, an antiretroviral medication used in HIV treatment, with delivery to Park Ridge, Illinois and a completion deadline of September 30, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's status as a...
- This delivery order, valued at $1,429.30, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isentress 400 mg tablets (60-count units). The award was issued on June 6, 2025, under a firm fixed-price contract type with an ultimate completion date of June 11, 2025. The product will be delivered to Park Ridge, Illinois, and the contract was funded by the Defense Logistics Agency's Medical Supply Chain...
- On August 28, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $2,093.62 to DMS Pharmaceutical Group Inc. for the supply of Isentress 400 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of August 29, 2025. This delivery order was issued without a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg tablet. The order has a potential value of $1,336.79 and a completion date of April 4, 2023. DMS Pharmaceutical Group holds multiple federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products in support of military treatment facilities...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg Tablet. The potential value of this order is $2,541.64 and the period of performance runs through February 23, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F103GDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,429.30 for 60 tablets of Isentress 400 mg on June 3, 2025, with an ultimate completion date of June 6, 2025. The contract carries no set-aside designation and is funded through the Medical Supply Chain, a Defense agency component. This delivery order represents a single pharmaceutical transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026. The award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare facilities. Isentress, an antiretroviral medication used in HIV treatment, falls within the company's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed to military and federal healthcare systems nationwide. The firm's consistent success in federal procurement, demonstrated through its numerous prior awards across various pharmaceutical product categories, underscores its capability to rapidly fulfill specialized medication requirements for government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/3/25 |